Heal Capital closes debut fund on €100m
Healthtech-focused venture capital firm Heal Capital has held a final close for its debut fund on €100m.
More on Venture
2150 holds first close on €130m for debut fund
It plans to back 20 companies, offering equity cheques of up to €40m across the life of an investment
Skylake Capital holds first close, makes first deal
Debut fund leads a $3m round in UK-based deep-learning startup Mindtrace
Advent Life Sciences raises $215m across two new funds
Funds invest in early- and mid-stage life sciences companies developing new therapeutics and technologies
Passion Capital closes venture secondaries deal
Fund closed in 2011 on £37.5m but now boasts a NAV north of £100m
Latest News
L Catterton acquires Birkenstock
German footwear company is reportedly valued at around €4bn and drew interest from several PE buyers
Hiro Capital invests $15m in three gaming studios
Funding will help the studios expand their development pipelines and accelerate global growth
Partners Group buys Parmaco from Terra Firma-led group
Vendors reportedly sought a valuation of between €800m-1bn for the company
P101 invests €6m in series-B for Bipi Mobility
P101 deploys capital from its Programma 102 and Italia 500 vehicles for the deal